The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of biweekly TAS-102, irinotecan and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO).
 
Patrick M Boland
Consulting or Advisory Role - Bayer; Guardant Health; Merck; Pfizer
Research Funding - Amgen (Inst); Macrogenics (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)
 
Sarbajit Mukherjee
Research Funding - Ipsen (Inst)
Other Relationship - Esophageal Cancer Action Network (ECAN)
 
Iman Imanirad
Employment - Allergy, Asthma & Immunology Associates (I)
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - MyCareGorithm; signatera
 
Namrata Vijayvergia
Honoraria - Guidepoint Global
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Ipsen; ITM Isotope Technologies Munich; Novartis; RayzeBio; Taiho Oncology; Tersera
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Oryzon Genomics (Inst); Puma Biotechnology (Inst); Zymeworks (Inst)
 
Seth D. Cohen
No Relationships to Disclose
 
Medhavi Gupta
No Relationships to Disclose
 
Renuka V. Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Bayer; Eisai; Exelixis; Incyte; Ipsen; Lexicon; Merck; Novartis; QED therapeutics; Sandoz; Sun pharma; Tersera
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Sarah Chatley
No Relationships to Disclose
 
Beth Cahill
No Relationships to Disclose
 
Deepak Vadehra
No Relationships to Disclose
 
Kristopher Attwood
No Relationships to Disclose
 
Howard S. Hochster
Stock and Other Ownership Interests - Compass Therapeutics; Processa Pharmaceuticals
Consulting or Advisory Role - Bayer; Genentech; Merck
Speakers' Bureau - Natera
 
Christos Fountzilas
Research Funding - Aravive (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bellicum Pharmaceuticals (Inst); Bristol-Myers Squibb/Ono Pharmaceutical (Inst); Corcept Therapeutics (Inst); CrystalGenomics (Inst); Dragonfly Therapeutics (Inst); ERYTECH Pharma (Inst); Incyte (Inst); Ipsen (Inst); Kadmon (Inst); Kinex (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Syndax (Inst); Taiho Oncology (Inst); TransThera Biosciences (Inst)